---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-041250"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2026-09-02T20:47:43+00:00"
generated_at: "2026-09-02T20:49:08.226904+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# SRX Global completes senior secured debt investment in CERo up to $11.67M

## Summary
- Note consolidates prior convertible notes totaling $5,666,108.77; additional advances up to $6,000,000 for $11,666,108.77 max.
- Initial advance of $775,665 funded Aug 27, 2026 for working capital; 10% annual interest (24.99% default).
- Maturity Oct 15, 2026; extendable up to four 30-day periods; secured by CERo subsidiary stock and CER-1236 assets, plus guarantee.
- CER-1236 Phase 1 CERTAIN-T: six patients dosed, no DLTs in latest cohort; third cohort (1B cells/patient) expands to MDS and myelofibrosis.

## SEC filing metadata
- accession: 0001493152-26-041250
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2026-09-02T20:47:43+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000149315226041250/0001493152-26-041250-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000149315226041250/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-041250
- JSON: https://secwatch.observer/filing/0001493152-26-041250.json
- Plain text: https://secwatch.observer/filing/0001493152-26-041250.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.